News
Zydus follows Lupin with Myrbetriq settlement deal
Zydus has joined Lupin in agreeing to settle patent litigation with Astellas on its generic of big-selling overactive bladder drug Myrbetriq.
News
FDA says comparator dose scuppered Moderna's flu jab filing
The FDA has defended its decision to issue a refusal-to-file (RTF) letter for Moderna's new mRNA-based influenza vaccine.
News
Hudson out at Sanofi, as Belén Garijo named CEO
The board at Sanofi has said it will not renew CEO Paul Hudson's contract, and has turned to former Merck CEO Belén Garijo to lead the group.
Sales & Marketing
Sponsored
Using AI-driven synthetic personas to take your insights fur...
As AI continues to reshape the healthcare landscape, pharma teams are beginning to leverage synthetic personas.
News
Inept digital interaction undermining pharma with clinicians
More than half of clinicians polled about digital pharma communications have said they tend to be over-promotional and not helpful.
News
Press Releases
Views & Analysis
Editor's Picks
Editor's Picks
